Congenital Rubella Syndrome (CRS)
The epidemiology of rubella changed in the 1990s, including shifts in the age distribution, ethnicity, and country of origin of patients, and in the setting of outbreaks (CDC, 2014-b).
By 1977, vaccination of children 12 months of age and older had resulted in a marked decline in the reported rubella incidence among children and had interrupted the characteristic 6- to 9-year rubella epidemic cycle. However, this vaccination strategy had less effect on reported rubella incidence among persons 15 years of age and older (i.e., childbearing ages for women) who subsequently accounted for more than 70% of reported rubella patients with known ages. Approximately 10%-20% of this latter population continued to be susceptible, a proportion similar to that of prevaccine years, and reported CRS continued at a low but constant endemic level (an annual average of 32 reported confirmed and compatible cases* between 1971 and 1977) (CDC, 1998-b).
How is the vaccine made?
There are three components to the MMR. Each having a unique live virus grown in its own culture. The live measles virus (Attenuvax) is grown in a chick embryo cell culture called medium 199 (Mabids, 2013). The live viral mumps (Mumpsvax) is also grown in medium 199 (Mabids, 2013), and the rubella virus (Meruvax) is grow in a buffered salt solution with fetal bovine serum, human serum albumin and neomycin (an antiboiotic) and it's propagation medium is called "WI-38 human diploid lung fibroblasts" (Mabids, 2013). WI-38 cultures according to Plotkin et al are derived from a "fetus that was surgically aborted 17 days after the maternal illness and dissected immediately" (Plotkin et al, 1965). the vaccine's complementary ingredients include sucrose, sodium phosphate, monosodium L-glutamate (MSG), sorbitol, hydrolyzed gelatin stabilizer and sodium chloride (Merck, 2009).
There are four components to the MMRV. Like the MMR there are four unique live viral agents grown in its own culture. The strain of measles in this vaccine is called Enders' attenuated Edmonston strain and just like the MMR is cultivated in a chick embryo cell culture. The mumps strain used (Jeryl Lynn: B level) is also propagated in chick embryo, and the rubella virus (Wistar RA 27/3) is propagated in the same WI-38 human diploid lung fibroblasts (aborted fetuses) as in the MMR. The varicella virus (Oka/Merck), is propagated in MRC-5 cells (aborted fetuses). This vaccine also has complementary ingredients such as sucrose, hydrolyzed gelatin, sodium phosphate, human albumin, sodium bicarbonate, potassium phosphate, potassium chloride, DNA and protein, neomycin, bovine serum albumin, and other buffer and media ingredients (MMRV: ProQuad, 2014).
The live measles vaccine and MMR, and MMRV has never been manufactured with the mercury derivative thimerosal because this preservative kills all living compounds that it comes in contact with making the vaccine useless to its design.
A comparative field trial of three live, attenuated rubella virus vaccines (Cendehill, HPV 77 DE-5, and HPV-77 DK-12) was initiated in 1969 on the islands of Kauai and Hawaii in the state of Hawaii. Following initial seroconversion rates of more than 98%, periodic serological testing of the study population was conducted to assess the durability of vaccine-induced immunity. In February 1980, ten years after the initiation of the study, 741 of the 5,153 original susceptible vaccinees were still enrolled in the study. After a drop of approximately 50% in mean hemagglutination-inhibition (HI) titer for each of the vaccine groups during the first four years following vaccination, the HI titer levels for all three groups have been generally stable between years 4 and 10. The frequency of reversion to an HI titer of less than 10 has remained less than 0.5% per year. A measurable HI antibody level has persisted in more than 97% of all vaccines over the ten-year period. This study indicates that when potent rubella vaccine is administered properly, a high seroconversion rate and a high rate of antibody persistence should be expected (Herrmann et al., 1982).
Admitted Events From The Mainstream
Anaphylaxis or anaphylactic shock, Encephalopathy (or encephalitis), Any acute complication or sequela (including death) of an illness, disability, injury, or condition referred to above which illness, disability, injury, or condition arose within the time period prescribed. Chronic arthritis, Thrombocytopenic purpura, Vaccine-Strain Measles Viral Infection in an immunodeficient recipient (HRSA, n.d.).
MMR II has not been evaluated for carcinogenic or mutagenic potential, or potential to impair fertility... It is also not known whether MMR II can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity (Merck, 2009).
Diabetes mellitus, subacute sclerosing panencephalitis (SSPE), Guillain-Barre Syndrome (GBS), febrile convulsions, afebrile convulsions or seizures, ataxia, polyneuritis, polyneuropathy, ocular palsies, paresthesia, pneumonia, pneumonitis, Stevens-Johnson syndrome, erythema multiforme, urticaria, nerve deafness, otitis media, retinitis, optic neuritis, epididymitis, orchitis (Merck, 2009).
Long-term seizures, coma, or lowered consciousness, PERMANENT BRAIN DAMAGE [emphasis added] (CDC, n.d.).
Encephalitis is inflammation of the brain that occurs when a virus directly infects the brain or when a virus, vaccine, or something else triggers inflammation. The spinal cord may also be involved, resulting in a disorder called encephalomyelitis (Merck Manual, 2013).
The government has not compensated any case based on a determination that autism, in the absence of acute neurological illness, was actually caused by vaccines. The government has compensated cases where a child showed sudden serious brain illness (called acute encephalopathy) at the time of vaccination. Some of these compensated children go on to develop long term medical and developmental problems. These problems may be the result of the brain illness or may develop for other reasons. Long term medical problems may include seizures, cerebral palsy, developmental delay, mental retardation, as well as the diagnosis of autism (Newton, N., 2013).
Clinical and scientific data is steadily accumulating that the live measles virus in MMR can cause brain, gut and immune system damage in a subset of vulnerable children... There's no one conclusive piece of scientific evidence, no 'smoking gun', because there very rarely is when adverse drug reactions are first suspected. When vaccine damage in very young children is involved, it is harder to prove the links... But it is the steady accumulation of evidence, from a number of respected universities, teaching hospitals and laboratories around the world, that matters here. There's far too much to ignore. Yet government health authorities are, it seems, more than happy to do so (Corrigan, S., 2006).
The Following Events Are Controversial
If you follow the reports made to VAERS you see that the MMR, MR is associated with adverse events affecting every body system. Some of the reports include; lymphadenopathy, leukocytosis, inflammatory bowel disease, Crohn’s disease, ulcerative colitis, meningitis, diabetes, autism etc... VAERS is a passive reporting system and the only vaccine surveillance system in the United States. All the adverse events reported to VAERS that the U.S. health authority or vaccine promoters find uncomfortable are simply waved away as unreliable. But VAERS is used quite reputably in other situations like the Haber et al study that found a signal of intussusception after exposure to the rotavirus vaccine (Haber et al., 2013). Chen et al produced a study which analyzed the reporting to VAERS and found that it plays an "important role in helping to monitor vaccine safety" (Chen et al., 1994). Even though vaccine promoters will point out that VEARS is guilty of erroneous reporting when they are faced with uncomfortable adverse events, it is well documented that the main flaw to the VAERS surveillance is "significant underreporting" (Rosenthal et al., 1995).
Scientific evidence demonstrates that individuals vaccinated with live virus vaccines such as MMR (measles, mumps and rubella), rotavirus, chicken pox, shingles and influenza can shed the virus for many weeks or months afterwards and infect the vaccinated and unvaccinated alike.1,2 3,4,5,6,7,8,9,10 (Weston A Price Foundation, 2015).
Challenge The Virus, Change The Disease
Acetaminophen, MMR, & Autism
National Vaccine Injury Compensation Program (NVIC)
The most famous court case is in regard to Hannah Poling. Dr. Andrew Zimmerman was the Department of Justice's (DOJ) expert witness in this case. Dr. Zimmerman is a pediatric neurologist and research scientist from the Kennedy Krieger Institute. He also is an associate professor of neurology and psychiatry at the Johns Hopkins University School of Medicine. In his detailed report to the Special Masters overseeing the NVICP's Cedillo v. HHS stated; "The cause for regressive encepahlopathy in Hannah (Poling) at age 19 months was underlying mitochondrial dysfunction, exacerbated by vaccine-induced fever and immune stimulation that exceeded metabolic energy reserves. This acute expenditure of metabolic reserves led to permanent irreversible brain injury. Thus, if not for this event, Hannah may have led a normal full productive life. Presently, I predict Hannah will have a normal lifespan but with significant lifelong disability" (Zimmerman Exhibit 3, 2007). I have heard arguments that Hannah was never diagnosed with autism, that Hannah was diagnosed with "autism like symptoms" and that this case was rare because of her underlying mitochondrial dysfunction. Hannah's father Dr. Poling is a licensed neurologist and his wife Terry a registered nurse filed their case alleging (and winning) that vaccines caused her autism (CNN Health, 2008). In regard that a mitochondrial dysfunction is somehow rare is yet another attempt to downplay vaccine adverse events. We now know that mitochondrial dysfunction is associated with children diagnosed with autism (Chauhan et al., 2011).
A recent Special Masters ruling filed in 2012 showed case awarded damages to Ryan B. Mojabi. One of the several medical DOJ expert witnesses stated; "all the vaccinations administered to [Ryan] from March 25, 2003, through February 22, 2005, and more specifically MMR vaccinations administered to him on December 19, 2003 and May 10, 2004, Ryan suffered a severe and debilitating injury to his brain, described as Autism Spectrum disorder (ASD). Ryan has suffered... neuroimmunologically mediated dysfunction in the form of asthma and ASD" (United States Court of Federal Claims, 2012).
There have been other cases won like the claim in Italy and more in the United States. November 2013 the Congressional Oversight Committee will be asking hard questions like why they closed the books of the NVICP to see just how many claimants have won on this basis of injury. If you wish to see a preliminary review of those documents please read Unanswered Questions from the Vaccine Injury Compensation Program: A Review of Compensated Cases of Vaccine-Induced Brain Injury (Holland et al., 2011)
MMR Vaccine Safety Analysis ~ Cochrane
So they are warning those that support the aggressive vaccine policy to not ignore the real adverse events associated with their agenda. The current safety analysis particularly with the MMR is not sufficient to make claims of overall safety. This statement was previously made by a Cochrane researcher in 2003 by Dr. Jefferson in his peer-review titled “Unintended events following immunization with MMR: a systematic review” (Jefferson et al, 2003). The authors conclusions in 2003 are identical to the conclusions made in 2012. You would think that in a 9 year period we could have had some answers regarding the safety outcomes of a vaccine administered to millions of children around the world!
Rubella Outbreaks In Vaccinated Populations
CRS does occur, it is frequently a result of asymptomatic rubella reinfection in the mother (5,6). In this case-patient, CRS was likely the result of 2 rare events: his mother’s lack of immunity after vaccination and her exposure to rubella in a highly immune population (CDC, 2014-c).
Vaccine derived herd immunity has not persisted in the United States for at least 40 years, and we have not seen a resurgent of massive epidemics. Vaccine induced herd immunity is used by public-health officials and providers to frighten those to adhere to a vaccine policy that is not even grounded in the belief system they propagate. This proves that there is no justification in forced vaccination. In a recent outbreak the issue of measles spreading to adults with no immunity is discussed. The population that they presume is the least immune to measles are those born between 1970 and 1985 (Frketich, 2013). This is blamed on the “youngish adults” not having had the natural infection and not being vaccine compliant. So here again we find the level of presumed “herd immunity” well below the needed rate to prevent massive disease outbreaks and yet the disease is relatively non existent.
Reported Vaccine Adverse Events
1,073 Life Threatening 76.33% under the age of 6
27,600 ER Visit 77.61% under the age of 6
2,844 Hospitalized 74.37% under the age of 6
77 Extended Hospital Stay 75.32% under the age of 6
687 Disabled 74.97% under the age of 6
212 Died 69.81% under the age of 6
Statistics from 2011
According to the CDC there have been reports of CRS but they are all unpublished reports, therefore the original source material is not able to be reviewed and compared (CDC, 2014-b).
2,943 Vaccine Adverse Events were reported in the U.S., 73.46% < age of 6 (MedAlerts, 2013).
12 Disabled 83.33% under the age of 6
12 Died 83.34% under the age of 6
199 Hospitalized (did not die or become disabled) 73.87% under the age of 6
MMR Vaccine Banned In Japan
Instead of trying to understand the uptake in adverse events and more particularly the finding of the vaccine measles strain in the cerebrospinal fluid (described above under vaccine risks) vaccine promoters took this opportunity to construct junk science to disprove the MMR/autism connection to promote vaccine uptake rates (Honda et al. 2005). There are 13 main critiques of this study and undisclosed conflicts of interest regarding co-author Michael Rutter who was a paid witness in MMR litigation and who is affiliated with the vaccine manufacturer GlaxoSmithKline (SafeMinds, n.d. pg.31).
CDC. (1998). Summary of Notifiable Diseases, United States, 1995. MMWR. Retrieved from http://www.cdc.gov/mmwr/preview/mmwrhtml/00044418.htm#00001093.gif
CDC. (1998-b). Recommendation of the immunization practices advisory committee (ACIP) rubella prevention. CDC Prevention Guidelines Database. Retrieved from http://wonder.cdc.gov/wonder/prevguid/p0000360/p0000360.asp
CDC. (2013). Three cases of congenital rubella syndrome in the postelimination era - Maryland, Alabama, and Illinois, 2012. Morbidity and Mortality Weekly Report. Retrieved from http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6212a3.htm
CDC. (2014). Chapter 15: congenital rubella syndrome. Centers For Disease Control. Retrieved from http://www.cdc.gov/vaccines/pubs/surv-manual/chpt15-crs.html
CDC. (2014-b). Chapter 15: Congential rubella syndrome. Vaccines and Immunizations. Retrieved from http://www.cdc.gov/vaccines/pubs/surv-manual/chpt15-crs.html
CDC. (2014-c). Congenital rubella syndrome in child of woman witout known risk factors, New Jersey, USA. Emerging Infectious Disease. Retrieved from http://wwwnc.cdc.gov/eid/article/20/2/13-1233_article
Chauhan et al. (2011). Brain region-specific deficit in mitochondrial electron transport chain complexes in children with autism. J Neurochem. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/21250997
Chen et al. (1994). The vaccine adverse event reporting system (VAERS). Vaccine. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/8036829
Cherry, J. (1980). The 'new' epidemiology of measles and rubella. hospital practice. Retrieved from http://www.researchgate.net/publication/15798594_The_%27new%27_epidemiology_of_measles_and_rubella
CNN Health. (2008). vaccine case draws new attention to autism debate. Retrieved from http://www.cnn.com/2008/HEALTH/conditions/03/06/vaccines.autism/index.html
Corrigan, S. (2006). Former science chief: 'MMR fers coming true'. Daily Mail. Retrieved from http://www.dailymail.co.uk/health/article-376203/Former-science-chief-MMR-fears-coming-true.html
Demicheli et al. (2012). Vaccines for measles, mumps and rubella in children. Cochrane Database Syst Rev. Retrieved fromhttp://www.ncbi.nlm.nih.gov/pubmed/22336803
Farinati et al. (2007). Hepatits C virus: From oxygen free radicals to hepatocellular carcinoma. Journal of Viral Hepatitis. Retrieved from http://www.medscape.com/viewarticle/568426
Frketich, J. (2013). Measles spreading to adults with no immunity. the spec.com. Retrieved from http://www.thespec.com/news-story/3921529-measles-spreading-to-adults-with-no-immunity/
Furione et al. (1993). Polioviruses with natural recombinant genomes isolated from vaccine-associated paralytic poliomyelitis. Virology. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/8102826
HRSA. (n.d.). Vaccine injury table. Health Resources and Services Administration. Retrieved from http://www.hrsa.gov/vaccinecompensation/vaccinetable.html
Haber et al. (2013). Intussusception after rotavirus vaccines reported to US VAERS, 2006-2012. Pediatrics. Retrieved fromhttp://pediatrics.aappublications.org/content/early/2013/05/08/peds.2012-2554.abstract
Holland et al. (2011). Unanswered Questions from the Vaccine Injury Compensation Program: A Review of Compensated Cases of Vaccine-Induced Brain Injury. Pace Environmental Law Review. Retrieved from http://digitalcommons.pace.edu/cgi/viewcontent.cgi?article=1681&context=pelr
Honda et al. (2005). No effect of MMR withdrawal on the incidence of autism: a total population study. Journal of Child Psychology and Psychiatry. Retrieved fromhttp://www.ncbi.nlm.nih.gov/pubmed/15877763
Hope, J. (n.d.). Why Japan banned MMR vaccine. Mail Online. Retrieved from http://www.dailymail.co.uk/health/article-17509/Why-Japan-banned-MMR-vaccine.html
Jefferson et al. (2003). Unintended events following immunization with MMR: a systematic review. Vaccine. Retrieved from http://search.yahoo.com/r/_ylt=A0oGdUenOg1SEDkA6jlXNyoA;_ylu=X3oDMTEzODVmaXVlBHNlYwNzcgRwb3MDMQRjb2xvA3NrMQR2dGlkA1NNRTI1NV8x/SIG=1365uhrlo/EXP=1376627495/**http%3a//www.vaccinesafetyfirst.com/pdf/MMR%2520adverse%2520events%2520Jefferson.pdf
Landaverde et al. (2001). Poliomyelitis outbreak caused by vaccine-derived virus in Haiti and the Dominican Republic. Rev Panam Salud Publica. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/11418973
Landrigan, P. (2010). What causes autism? Exploring the environmental contribution. Curr Opin Pediatr. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/20087185
Lynn et al. (2004). Acetaminophen-induced oxidat stress and cell injury in cultured mouse hepatocytes: protection by N-Acetyl Cysteine. Toxicological Sciences. Retrieved from http://www.glutathioneexperts.com/glutathione-acetaminophen-7.html
MedAlerts. (2013). Search the VAERS Database. Retrieved from http://www.medalerts.org/vaersdb/index.php
Mabids. (2013). MMR vaccine- how is it made?. Retrieved fromhttp://mmrvaccine.info/mmr-vaccine-how-is-it-made/
MedicineNet.com. (2014). Rubella (German Measles). Medicine Net.com. Retrieved from http://www.medicinenet.com/german_measles/article.htm
MedlinePlus. (2014). Rubella. U.S. National Library. Retrieved from http://www.nlm.nih.gov/medlineplus/ency/article/001574.htm
Merck. (2009). MMR II Measles, Mumps, and Rubella Virus Vaccine Live. Merck sharp & Dohme Corp. page 6. Retrieved fromhttp://www.merck.com/product/usa/pi_circulars/m/mmr_ii/mmr_ii_pi.pdf
Merck Manual. (2013). Encephalitis. The Merck Home Health Handbook. Retrieved from http://www.merckmanuals.com/home/brain_spinal_cord_and_nerve_disorders/brain_infections/encephalitis.html
Newton, N. (2013). Article stirs autism and vaccine debate. MyFOXaustin. Retrieved from http://www.myfoxaustin.com/story/23150257/article-stirs-autism-and-vaccine-debate
Orenstein et al. (1981). Rubella vaccine and susceptible hospital employees poor physician participation. JAMA. Retrieved from http://jama.jamanetwork.com/article.aspx?articleid=373778
Plotkin et al. (1965). Studies of immunization with living rubella virus. Amer J Dis Child. Retrieved from http://search.yahoo.com/r/_ylt=A0oGkk8QswtSah8AoVBXNyoA;_ylu=X3oDMTEzODVmaXVlBHNlYwNzcgRwb3MDMQRjb2xvA3NrMQR2dGlkA1NNRTI1NV8x/SIG=12gu55rq8/EXP=1376527248/**http%3a//www.cogforlife.org/AmJDisChildPlotkinRubellaVirus.pdf
Rose et al. (2012). Evidence of oxidative damage and inflammation associated with low glutathione redox status in the autism brain. Translational Psychiatry. Retrieved from http://www.nature.com/tp/journal/v2/n7/full/tp201261a.html
Rosenthal et al. (1995). The reporting sensitivites of two passive surveillance systems for vaccine adverse events. Am J Public Health. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/7503351?dopt=Abstract
SafeMinds. (n.d.). Vaccines and autism-what do epidemiological studies really tell us. Retrieved from http://www.safeminds.org/research/library/SafeMinds%20Epidemiological%20Rebuttal.pdf
Schlenker et al. (1992). The association of attack rates with immunization rates in preschool children. JAMA. Retrieved fromhttp://jama.jamanetwork.com/article.aspx?articleid=395057
Schultz et al. (2008). Acetaminophen (paracetamol) use, measles-mumps-rubella vaccination, and autistic disorder: the results of a parent survey. Autism. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/18445737
Smith, M. (2013). School-entry shots near national targets. MedPage. Retrieved from http://www.medpagetoday.com/Pediatrics/Vaccines/40793?xid=nl_mpt_DHE_2013-08-02&utm_content&utm_medium=email&utm_campaign=DailyHeadlines&utm_source=WC&eun=g664758d0r&userid=664758&email=hxwhite%40hotmail.com&mu_id=5828456
United States Court of Federal Claims. (2012). Saeid B. Mojabi and Parivash Vahabi V. Secretary of Health and Human Services. Retrieved from http://www.scribd.com/doc/120285036/Saeid-B-Mojabi-and-Parivash-Vahabi-v-Secretary-Of-Health-And-Human-Services
Zimmerman, Andrew. Exhigit 3. (2007). Hannah Poling (DOB: 12/27/98); Report of the Office of Speical Masters, United States Court of Federal Claims, November 9, 2007. Retrieved from http://www.scribd.com/doc/115393727/Andrew-Zimmerman-Poling-v-HHS-Exhibit-3